Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.14 USD | -1.19% | +2.48% | -39.62% |
Apr. 17 | Evaxion Announces Phase 2 Clinical Trial Update | CI |
Apr. 11 | European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.62% | 21.59M | |
+3.13% | 43.43B | |
+48.88% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+32.83% | 12.59B | |
+1.58% | 12.33B | |
+6.63% | 11.03B |
- Stock Market
- Equities
- EVAX Stock
- News Evaxion Biotech A/S
- Evaxion Biotech Says it has Secured Up To $40 Million in Equity Financing From Lincoln Park Capital